Teresa Mattarelli
Corporate Officer/Principal at Perspectum Group Ltd.
Profile
Teresa Mattarelli is currently the Chief Commercial Officer at Perspectum Group Ltd.
Prior to this, she worked at Medtronic Plc as the Global Vice President & General Manager from 2019 to 2020.
She completed her undergraduate degree and MBA from McGill University.
Teresa Mattarelli active positions
| Companies | Position | Start |
|---|---|---|
Perspectum Group Ltd.
 Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 2021-01-31 |
Former positions of Teresa Mattarelli
| Companies | Position | End |
|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | 2020-10-31 |
Training of Teresa Mattarelli
| McGill University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MEDTRONIC PLC | Health Technology |
| Private companies | 1 |
|---|---|
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Technology Services |
- Stock Market
- Insiders
- Teresa Mattarelli
